Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4295) 4295
Publication (902) 902
Book Chapter (74) 74
Book Review (31) 31
Conference Proceeding (30) 30
Book / eBook (7) 7
Magazine Article (2) 2
Data Set (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cell-free system (2219) 2219
humans (2165) 2165
index medicus (1904) 1904
animals (1307) 1307
biochemistry & molecular biology (1043) 1043
female (938) 938
dna (834) 834
cell-free dna (724) 724
base sequence (701) 701
protein biosynthesis (656) 656
molecular sequence data (641) 641
proteins (568) 568
cell biology (539) 539
deoxyribonucleic acid--dna (537) 537
male (536) 536
transcription, genetic (524) 524
mutation (508) 508
research (507) 507
research article (477) 477
cancer (468) 468
multidisciplinary sciences (447) 447
pregnancy (434) 434
analysis (421) 421
rna (398) 398
plasma (390) 390
adult (389) 389
genetics & heredity (383) 383
oncology (382) 382
genetic aspects (370) 370
middle aged (332) 332
article (322) 322
mice (313) 313
rna, messenger - genetics (312) 312
amino acid sequence (308) 308
diagnosis (300) 300
dna - blood (300) 300
biomarkers (297) 297
rna, messenger - metabolism (290) 290
gene expression (288) 288
genes (288) 288
medicine (281) 281
hela cells (280) 280
nucleic acid hybridization (279) 279
nucleic acid conformation (277) 277
blood (276) 276
cell line (266) 266
biochemistry (262) 262
escherichia-coli (253) 253
genetic research (252) 252
polymerase chain reaction (251) 251
aged (249) 249
dna - genetics (246) 246
protein binding (246) 246
serum (244) 244
maternal plasma (235) 235
obstetrics & gynecology (225) 225
kinetics (223) 223
biology (221) 221
expression (219) 219
in-vitro (217) 217
science (217) 217
physiological aspects (212) 212
messenger-rna (210) 210
templates, genetic (209) 209
dna - metabolism (207) 207
biotechnology & applied microbiology (206) 206
prognosis (201) 201
rabbits (198) 198
cloning, molecular (195) 195
dna methylation (193) 193
viruses (191) 191
prenatal diagnosis - methods (189) 189
enzymes (188) 188
aneuploidy (187) 187
apoptosis (187) 187
escherichia coli - genetics (178) 178
cell-free system - metabolism (177) 177
genomes (177) 177
health aspects (177) 177
cell-free nucleic acids - blood (175) 175
dna-binding proteins - metabolism (174) 174
biomarkers, tumor - blood (173) 173
prenatal diagnosis (173) 173
pregnant women (172) 172
tumors (171) 171
liquid biopsy (170) 170
nucleic-acids (169) 169
plasmids (169) 169
messenger rna (168) 168
molecular biology (166) 166
rats (166) 166
virology (166) 166
plasma dna (164) 164
cell-free nucleic acids - genetics (161) 161
protein (161) 161
escherichia coli - metabolism (159) 159
genomics (159) 159
cell nucleus - metabolism (158) 158
genetics (158) 158
promoter regions, genetic (158) 158
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4267) 4267
Japanese (18) 18
Russian (12) 12
Chinese (11) 11
German (6) 6
Korean (3) 3
French (2) 2
Spanish (2) 2
Czech (1) 1
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Circular RNA ciRS-7 — A promising prognostic biomarker and a potential therapeutic target in colorectal cancer
by Weng, Wenhao and Wei, Qing and Toden, Shusuke and Yoshida, Kazuhiro and Nagasaka, Takeshi and Fujiwara, Toshiyoshi and Cai, Sanjun and Qin, Huanlong and Ma, Yanlei and Goel, Ajay
Clinical Cancer Research, ISSN 1078-0432, 07/2017, Volume 23, Issue 14, pp. 3918 - 3928
Purpose: Colorectal cancer is one of themost common malignancies worldwide. Recently, a novel circular RNA, ciRS-7, was proposed to be a potential miR-7... 
LUNG-CANCER | STEM-LIKE CELLS | MICRORNA-7 | ONCOLOGY | GROWTH | TUMOR-SUPPRESSOR | RECEPTOR | PROLIFERATION | MECHANISMS | EXPRESSION | MIR-7 | Receptor, Epidermal Growth Factor - genetics | Cell Proliferation - genetics | Prognosis | Proto-Oncogene Proteins c-raf - genetics | Colorectal Neoplasms - genetics | Humans | Middle Aged | Gene Expression Regulation, Neoplastic | Male | Cell-Free Nucleic Acids - genetics | HT29 Cells | Female | Aged | Biomarkers, Tumor - genetics | MicroRNAs - genetics | Colorectal Neoplasms - pathology | Epidermal growth factor receptors | Colorectal carcinoma | Colorectal cancer | Tissues | Ribonucleic acid--RNA | Survival | Patients | Risk factors | Training | Survival analysis | Experimental design | Cell lines | Biomarkers | Circular RNA | Bioindicators | Cancer | miR-7 | circular RNA | miRNA | ciRS-7 | RAF1 | EGFR
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients
by Sorber, L and Zwaenepoel, K and Deschoolmeester, V and Van Schil, P.E.Y and Van Meerbeeck, J and Lardon, F and Rolfo, C and Pauwels, P
Lung Cancer, ISSN 0169-5002, 2016, Volume 107, pp. 100 - 107
Highlights • Tissue and Liquid Biopsy can be combined in the provision of personalized therapy. • We discuss the clinical applications of cfDNA as a Liquid... 
Hematology, Oncology and Palliative Medicine | Pulmonary/Respiratory | Cell-free DNA | Liquid biopsy | Tumor-related RNA | Platelets | Non-small cell lung cancer | BLOOD COLLECTION | 1ST-LINE TREATMENT | PLASMA DNA | FREE DNA | ACQUIRED-RESISTANCE | OPEN-LABEL | RESISTANCE MUTATIONS | PICODROPLET DIGITAL PCR | EGFR T790M MUTATION | ONCOLOGY | RESPIRATORY SYSTEM | TUMOR DNA | Blood Platelets - pathology | Receptor, Epidermal Growth Factor - genetics | Prognosis | Genomics | Humans | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Cell-Free Nucleic Acids - genetics | DNA, Neoplasm - blood | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Liquid Biopsy - methods | Lung Neoplasms - therapy | Biomarkers, Tumor - blood | Carcinoma, Non-Small-Cell Lung - therapy | Protein Kinase Inhibitors - therapeutic use | Cell-Free Nucleic Acids - blood | Carcinoma, Non-Small-Cell Lung - blood | Biomarkers, Tumor - genetics | High-Throughput Nucleotide Sequencing | Lung Neoplasms - blood | Mutation | Neoplasm Staging | Precision Medicine - methods | Care and treatment | RNA | Health aspects | Analysis | Cancer | Usage | Lung cancer, Non-small cell
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Circulating cell-free DNA to guide prostate cancer treatment with PARP inhibition
by Goodall, Jane and Mateo, Joaquin and Yuan, Wei and Mossop, Helen and Porta, Nuria and Miranda, Susana and Perez-Lopez, Raquel and Dolling, David and Robinson, Dan R and Sandhu, Shahneen and Fowler, Gemma and Ebbs, Berni and Flohr, Penny and Seed, George and Rodrigues, Daniel Nava and Boysen, Gunther and Bertan, Claudia and Atkin, Mark and Clarke, Matthew and Crespo, Mateus and Figueiredo, Ines and Riisnaes, Ruth and Sumanasuriya, Semini and Rescigno, Pasquale and Zafeiriou, Zafeiris and Sharp, Adam and Tunariu, Nina and Bianchini, Diletta and Gillman, Alexa and Lord, Christopher J and Hall, Emma and Chinnaiyan, Arul M and Carreira, Suzanne and De Bono, Johann S and Toparp-A Investigators and TOPARP-A investigators
Cancer Discovery, ISSN 2159-8274, 09/2017, Volume 7, Issue 9, pp. 1006 - 1017
Biomarkers for more precise patient care are needed in metastatic prostate cancer. We have reported a phase II trial (TOPARP-A) of the PARP inhibitor olaparib... 
BIOMARKER | ONCOLOGY | MEN | RESISTANCE | HOMOLOGY-DIRECTED REPAIR | MUTATIONS | BRCA2 | TUMORS | Prognosis | Gene Frequency | Humans | Male | Antineoplastic Agents - therapeutic use | Piperazines - therapeutic use | Cell-Free Nucleic Acids - genetics | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Whole Exome Sequencing | Phthalazines - therapeutic use | Prostatic Neoplasms - genetics | Cell-Free Nucleic Acids - blood | Prostatic Neoplasms - blood | Mutation | Prostatic Neoplasms - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
by Adalsteinsson, Viktor A and Ha, Gavin and Freeman, Samuel S and Choudhury, Atish D and Stover, Daniel G and Parsons, Heather A and Gydush, Gregory and Reed, Sarah C and Rotem, Denisse and Rhoades, Justin and Loginov, Denis and Livitz, Dimitri and Rosebrock, Daniel and Leshchiner, Ignaty and Kim, Jaegil and Stewart, Chip and Rosenberg, Mara and Francis, Joshua M and Zhang, Cheng-Zhong and Cohen, Ofir and Oh, Coyin and Ding, Huiming and Polak, Paz and Lloyd, Max and Mahmud, Sairah and Helvie, Karla and Merrill, Margaret S and Santiago, Rebecca A and O'Connor, Edward P and Jeong, Seong H and Leeson, Rachel and Barry, Rachel M and Kramkowski, Joseph F and Zhang, Zhenwei and Polacek, Laura and Lohr, Jens G and Schleicher, Molly and Lipscomb, Emily and Saltzman, Andrea and Oliver, Nelly M and Marini, Lori and Waks, Adrienne G and Harshman, Lauren C and Tolaney, Sara M and Van Allen, Eliezer M and Winer, Eric P and Lin, Nancy U and Nakabayashi, Mari and Taplin, Mary-Ellen and Johannessen, Cory M and Garraway, Levi A and Golub, Todd R and Boehm, Jesse S and Wagle, Nikhil and Getz, Gad and Love, J. Christopher and Meyerson, Matthew
Nature Communications, ISSN 2041-1723, 12/2017, Volume 8, Issue 1, pp. 1324 - 13
Whole-exome sequencing of cell-free DNA (cfDNA) could enable comprehensive profiling of tumors from blood but the genome-wide concordance between cfDNA and... 
COMPREHENSIVE MOLECULAR PORTRAITS | BREAST-CANCER | LUNG-CANCER | EVOLUTION | SIGNATURES | MULTIDISCIPLINARY SCIENCES | PROSTATE-CANCER | PLASMA DNA | MUTATIONAL LANDSCAPE | CHRONIC LYMPHOCYTIC-LEUKEMIA | CIRCULAR BINARY SEGMENTATION | Antigens, Neoplasm - genetics | Breast Neoplasms - secondary | Prospective Studies | Humans | Male | Gene Dosage | Cell-Free Nucleic Acids - genetics | Breast Neoplasms - drug therapy | Whole Exome Sequencing - methods | Neoplasm Metastasis - genetics | Prostatic Neoplasms - secondary | Breast Neoplasms - genetics | Prostatic Neoplasms - genetics | DNA, Neoplasm - blood | Neoplasm Metastasis - drug therapy | DNA Mutational Analysis | Cell-Free Nucleic Acids - blood | Female | Software | DNA, Neoplasm - genetics | Prostatic Neoplasms - drug therapy | Whole Exome Sequencing - statistics & numerical data | Profiling | Identification methods | Copy number | Genomes | Metastasis | Patients | Blood | Gene sequencing | Metastases | Mutation | Prostate | Deoxyribonucleic acid--DNA | Tumors | DNA sequencing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer
by Jamal-Hanjani, M and Wilson, G.A and Horswell, S and Mitter, R and Sakarya, O and Constantin, T and Salari, R and Kirkizlar, E and Sigurjonsson, S and Pelham, R and Kareht, S and Zimmermann, B and Swanton, C
Annals of Oncology, ISSN 0923-7534, 05/2016, Volume 27, Issue 5, pp. 862 - 867
In this pilot study of early-stage NSCLCs, both ubiquitous and heterogeneous variants were identified in cfDNA from patients prior to tumor resection. Such... 
Non-small-cell lung cancer | Circulating cell-free DNA | Clonal | Subclonal | Intratumor heterogeneity | intratumor heterogeneity | LIQUID BIOPSY | CIRCULATING TUMOR DNA | VARIANTS | ONCOLOGY | clonal | circulating cell-free DNA | ACQUIRED-RESISTANCE | CLONAL EVOLUTION | subclonal | EGFR BLOCKADE | non-small-cell lung cancer | Carcinoma, Non-Small-Cell Lung - pathology | Carcinoma, Non-Small-Cell Lung - genetics | Humans | Middle Aged | Male | Cell-Free Nucleic Acids - genetics | Genetic Heterogeneity | Whole Exome Sequencing | DNA, Neoplasm - blood | Cell-Free Nucleic Acids - blood | Polymorphism, Single Nucleotide - genetics | Carcinoma, Non-Small-Cell Lung - blood | Female | Aged | DNA, Neoplasm - genetics | Mutation | Neoplasm Staging
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Long Noncoding RNAs as Biomarkers in Cancer
by Bolha, Luka and Ravnik-Glavač, Metka and Glavač, Damjan
Disease Markers, ISSN 0278-0240, 2017, Volume 2017, pp. 7243968 - 14
Long noncoding RNAs (lncRNAs) are a relatively well-characterized class of noncoding RNA (ncRNA) molecules, involved in the regulation of various cell... 
MEDICINE, RESEARCH & EXPERIMENTAL | CERVICAL-CANCER | TUMOR-SUPPRESSIVE FUNCTIONS | PATHOLOGY | MESENCHYMAL TRANSITION | HUMAN GLIOMA-CELLS | HEPATOCELLULAR-CARCINOMA | GASTRIC-CANCER | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | POOR-PROGNOSIS | PROSTATE-CANCER | GENETICS & HEREDITY | SQUAMOUS-CELL CARCINOMA | UP-REGULATION | Biomarkers, Tumor - blood | Neoplasms - blood | Neoplasms - genetics | Cell-Free Nucleic Acids - blood | Epigenesis, Genetic | Humans | RNA, Long Noncoding - blood | Biomarkers, Tumor - genetics | RNA, Long Noncoding - genetics | Cell-Free Nucleic Acids - genetics | Genetic markers | RNA | Oncology, Experimental | Genetic aspects | Research | Health aspects | Carcinogenesis | Cancer | Deregulation | Prognosis | Transcription | Trafficking | Medical diagnosis | Tissues | Ribonucleic acid--RNA | Patients | Chromatin remodeling | Body fluids | Biomarkers | Bioindicators | Diagnosis | Non-coding RNA | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer
by Barault, Ludovic and Amatu, Alessio and Siravegna, Giulia and Ponzetti, Agostino and Moran, Sebastian and Cassingena, Andrea and Mussolin, Benedetta and Falcomatà, Chiara and Binder, Alexandra M and Cristiano, Carmen and Oddo, Daniele and Guarrera, Simonetta and Cancelliere, Carlotta and Bustreo, Sara and Bencardino, Katia and Maden, Sean and Vanzati, Alice and Zavattari, Patrizia and Matullo, Giuseppe and Truini, Mauro and Grady, William M and Racca, Patrizia and Michels, Karin B and Siena, Salvatore and Esteller, Manel and Bardelli, Alberto and Sartore-Bianchi, Andrea and Di Nicolantonio, Federica
Gut, ISSN 0017-5749, 11/2018, Volume 67, Issue 11, pp. 1995 - 2005
ObjectiveMutations in cell-free circulating DNA (cfDNA) have been studied for tracking disease relapse in colorectal cancer (CRC). This approach requires... 
screening | tumour markers | colorectal cancer | chemotherapy | methylation | TRIAL | DIGITAL PCR | HYPERMETHYLATION | PLASMA | EARLY TUMOR SHRINKAGE | QUANTIFICATION | TISSUE | RESISTANCE | PHASE-II | MUTATIONS | GASTROENTEROLOGY & HEPATOLOGY | Oligonucleotide Array Sequence Analysis - methods | Colorectal Neoplasms - genetics | Humans | Middle Aged | Cell-Free Nucleic Acids - drug effects | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | DNA Methylation - genetics | Cell-Free Nucleic Acids - genetics | Drug Monitoring - methods | Biomarkers, Tumor - blood | Colorectal Neoplasms - drug therapy | Polymerase Chain Reaction | Cell Line, Tumor | Adult | Female | Aged | Biomarkers, Tumor - genetics | Mutation | Cell-Free Nucleic Acids - metabolism | Longitudinal Studies | Colorectal Neoplasms - metabolism | Pharmacodynamics | Invasiveness | Colorectal carcinoma | Colorectal cancer | Clinical trials | Population studies | Genomes | Metastasis | Gene expression | Patients | Metastases | Datasets | Studies | Chemotherapy | DNA microarrays | Biopsy | Cell lines | DNA methylation | Biomarkers | Epigenetics | Methylation | Deoxyribonucleic acid--DNA | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer
by Liu, Tong and Zhang, Xin and Gao, Shanyu and Jing, Fangmiao and Yang, Yongmei and Du, Lutao and Zheng, Guixi and Li, Peilong and Li, Chen and Wang, Chuanxin
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 51, pp. 85551 - 85563
Cancer-secreted long non-coding RNAs (lncRNAs) are emerging mediators of cancer-host cross talk. The aim of our study was to illustrate the clinical... 
CRNDE-h | Biomarker | Long noncoding RNA | Exosome | Colorectal cancer | LUNG | colorectal cancer | biomarker | IDENTIFICATION | BREAST | CELL BIOLOGY | PLASMA | MESSENGER-RNA | POOR-PROGNOSIS | GENES | long noncoding RNA | exosome | EXPRESSION | Exosomes - metabolism | Predictive Value of Tests | Up-Regulation | Prognosis | Area Under Curve | Colorectal Neoplasms - genetics | Humans | Middle Aged | Exosomes - genetics | Exosomes - pathology | Male | RNA, Long Noncoding - blood | Cell-Free Nucleic Acids - genetics | Case-Control Studies | Female | Colorectal Neoplasms - mortality | Reproducibility of Results | Colorectal Neoplasms - blood | HCT116 Cells | Kaplan-Meier Estimate | Proportional Hazards Models | RNA, Long Noncoding - genetics | RNA Stability | HT29 Cells | Pilot Projects | Animals | Mice, Nude | Cell-Free Nucleic Acids - blood | ROC Curve | Biomarkers, Tumor - genetics | Mice, Inbred BALB C | Colorectal Neoplasms - pathology | Biomarkers, Tumor - biosynthesis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Numerous uncharacterized and highly divergent microbes which colonize humans are revealed by circulating cell-free DNA
by Kowarsky, Mark and Camunas-Soler, Joan and Kertesz, Michael and De Vlaminck, Iwijn and Koh, Winston and Pan, Wenying and Martin, Lance and Neff, Norma F and Okamoto, Jennifer and Wong, Ronald J and Kharbanda, Sandhya and El-Sayed, Yasser and Blumenfeld, Yair and Stevenson, David K and Shaw, Gary M and Wolfe, Nathan D and Quake, Stephen R
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 09/2017, Volume 114, Issue 36, pp. 9623 - 9628
Blood circulates throughout the human body and contains molecules drawn from virtually every tissue, including the microbes and viruses which colonize the... 
Cell-free DNA | Metagenomics | Biological dark matter | Microbiome | biological dark matter | VIROME | metagenomics | REJECTION | MULTIDISCIPLINARY SCIENCES | cell-free DNA | DIVERSITY | microbiome | NONINVASIVE DIAGNOSIS | METAGENOMIC SAMPLES | DNA, Viral - blood | Genetic Variation | DNA, Bacterial - genetics | Microbiota - genetics | Cell-Free Nucleic Acids - blood | Humans | DNA, Bacterial - blood | Metagenomics - methods | Cell-Free Nucleic Acids - genetics | Phylogeny | DNA, Viral - genetics | High-Throughput Nucleotide Sequencing - methods | Microbiological research | Microorganisms | Genetic aspects | Research | DNA | Genomics | Biological Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text A prospective evaluation of circulating tumor cells and cell-free DNA in EGFR-mutant non-small cell lung cancer patients treated with erlotinib on a phase II trial
by Yanagita, Masahiko and Redig, Amanda J and Paweletz, Cloud P and Dahlberg, Suzanne E and O'Connell, Allison and Feeney, Nora and Taibi, Myriam and Boucher, David and Oxnard, Geoffrey R and Johnson, Bruce E and Costa, Daniel B and Jackman, David M and Jänne, Pasi A
Clinical Cancer Research, ISSN 1078-0432, 12/2016, Volume 22, Issue 24, pp. 6010 - 6020
Purpose: Genotype-directed therapy is the standard of care for advanced non-small cell lung cancer (NSCLC), but obtaining tumor tissue for genotyping remains a... 
TYROSINE KINASE INHIBITORS | GEFITINIB | THERAPY | ONCOLOGY | ADENOCARCINOMA | MUTATION | INTERNATIONAL-ASSOCIATION | ACQUIRED-RESISTANCE | SAMPLES | CHEMOTHERAPY | BLOOD | Lung Neoplasms - drug therapy | Prospective Studies | Neoplastic Cells, Circulating - pathology | Humans | Middle Aged | Receptor, Epidermal Growth Factor - deficiency | Cell-Free Nucleic Acids - drug effects | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Cell-Free Nucleic Acids - genetics | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Neoplastic Cells, Circulating - drug effects | Carcinoma, Non-Small-Cell Lung - genetics | Mutation - genetics | DNA, Neoplasm - drug effects | Disease Progression | Disease-Free Survival | Drug Resistance, Neoplasm - genetics | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Non-Small-Cell Lung - blood | Aged | Erlotinib Hydrochloride - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | DNA, Neoplasm - genetics | Drug Resistance, Neoplasm - drug effects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Fetal nucleic acids in maternal plasma: from biology to clinical translation
by Bunkar, N and Bhargava, A and Chaudhury, K and Sharma, RS and Lohiya, NK and Mishra, PK
FRONTIERS IN BIOSCIENCE-LANDMARK, ISSN 1093-9946, 01/2018, Volume 23, pp. 397 - 431
Exposure to environmental contaminants during the critical window of pregnancy results in deregulation of highly coordinated genetic and epigenetic mechanisms... 
OXIDATIVE STRESS | Environmental Health | LONG NONCODING RNAS | BIOCHEMISTRY & MOLECULAR BIOLOGY | PLACENTA-SPECIFIC MICRORNAS | Review | AMBIENT AIR-POLLUTION | CELL BIOLOGY | NONINVASIVE PRENATAL-DIAGNOSIS | Particulate matter | Biomarkers | BHOPAL GAS TRAGEDY | PREGNANT-WOMEN | Epigenetic modifications | COPY NUMBER VARIATION | HISTONE MODIFICATIONS | Circulating DNA | CELL-FREE DNA | Pregnancy | Maternal-Fetal Exchange | Fetal Blood - chemistry | Humans | Fetal Development | Female | Nucleic Acids - genetics | Biomarkers - blood | Nucleic Acids - blood | Prenatal Diagnosis - methods
Journal Article
Details down arrow
12. Full Text Diverse BRCA1 and BRCA2 reversion mutations in circulating cell-free DNA of therapy-resistant breast or ovarian cancer
by Weigelt, Britta and Comino-Méndez, Iñaki and De Bruijn, Ino and Tian, Lei and Meisel, Jane L and García-Murillas, Isaac and Fribbens, Charlotte and Cutts, Ros and Martelotto, Luciano G and Ng, Charlotte K.Y and Lim, Raymond S and Selenica, Pier and Piscuoglio, Salvatore and Aghajanian, Carol and Norton, Larry and Murali, Rajmohan and Hyman, David M and Borsu, Laetitia and Arcila, Maria E and Konner, Jason and Reis-Filho, Jorge S and Greenberg, Roger A and Robson, Mark E and Turner, Nicholas C
Clinical Cancer Research, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6708 - 6720
Purpose: Resistance to platinum-based chemotherapy or PARP inhibition in germline BRCA1 or BRCA2 mutation carriers may occur through somatic reversion... 
HETEROGENEITY | REPAIR | ONCOLOGY | LANDSCAPE | PATHWAY | ROLES | COPY NUMBER | PARP INHIBITORS | TUMOR DNA | Humans | Middle Aged | Ovarian Neoplasms - pathology | Ovarian Neoplasms - blood | Cell-Free Nucleic Acids - genetics | Platinum - administration & dosage | Breast Neoplasms - drug therapy | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Drug Resistance, Neoplasm - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Cell-Free Nucleic Acids - blood | Breast Neoplasms - blood | Germ-Line Mutation | Adult | Female | Aged | Mutation | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | BRCA2 protein | Immunoprecipitation | Ovarian carcinoma | BRCA1 protein | Introns | Exons | Recovery of function | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Metastases | Ovarian cancer | Gene sequencing | Reversion | Chemotherapy | Inhibitors | Experimental design | Platinum | Breast | Inhibition | Deoxyribonucleic acid--DNA | Cancer | reversion mutations | ovarian cancer | breast cancer | BRCA1 | BRCA2 | circulating cell-free plasma DNA | sequencing
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Subclonal Therapy by Two EGFR TKIs Guided by Sequential Plasma Cell-free DNA in EGFR-Mutated Lung Cancer
by Peled, Nir and Roisman, Laila C and Miron, Benjamin and Pfeffer, Raphael and Lanman, Richard B and Ilouze, Maya and Dvir, Addie and Soussan-Gutman, Lior and Barlesi, Fabrice and Tarcic, Gabi and Edelheit, Oded and Gandara, David and Elkabetz, Yehiel
Journal of Thoracic Oncology, ISSN 1556-0864, 07/2017, Volume 12, Issue 7, pp. e81 - e84
Lung Neoplasms - genetics | Humans | Middle Aged | ErbB Receptors - genetics | Female | Cell-Free Nucleic Acids - genetics | Mutation
Journal Article
Details down arrow
Digital rights down arrow